ribociclib and Adenomatous-Polyposis-Coli

ribociclib has been researched along with Adenomatous-Polyposis-Coli* in 1 studies

Other Studies

1 other study(ies) available for ribociclib and Adenomatous-Polyposis-Coli

ArticleYear
The CDK 4/6 inhibitor ribociclib has activity in the treatment of inoperable desmoid tumor. A case report.
    Acta oncologica (Stockholm, Sweden), 2019, Volume: 58, Issue:6

    Topics: Abdominal Neoplasms; Adenomatous Polyposis Coli; Adult; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Female; Fibromatosis, Aggressive; Goserelin; Humans; Letrozole; Protein Kinase Inhibitors; Purines; Young Adult

2019